News & Articles

Industry expert John Radke reveals how a reliable and transparent supply chain partner can be critical to weathering turbulent times

In this guest editorial, discover how genome editing in iPSCs can be a powerful tool to investigate the intricacies of the human genome

Nobelpharma will use ProBioGen’s cell-based production platform AGE1.CR.pIX to develop their lead vaccine

From tackling COVID-19 variants to therapeutic discovery, novel organoids and more, advance your assay research with these exclusive interviews and free resources

This week, explore topics ranging from fluorescence, confocal and TIRF microscopy to checkpoint inhibitor therapeutics

The cell lines offer researchers a diverse cohort of patient specific models to accelerate drug development

Register free today to join scientists from around the world as they come together to discuss the hottest topics and latest technology solutions

New application notes, videos and products

Watch exclusive interviews with leading industry experts on the importance of precision cold storage equipment

The autonomous cellufacturing facility aims to enable continuously scalable, cost-effective, automated food scale production of cell cultured human milk

First in Sphere Fluidics’ new range of 3D cell culture kits in partnership with ClexBio

Watch world-leading clinical scientists and healthcare professionals online, June 22-23, to discover the latest tools and techniques advancing COVID-19 diagnostic testing, cardiovascular treatments, point-of-care and more

Catch up on topics from A-TEEM spectroscopy and DNA sequencing to advances in in vitro diagnostics, advancing nano-material research with wet-chemical synthesis and biopharmaceutical R&D

Corning expands cell culture portfolio with 3D liver models that better recapitulate in vivo behavior and deliver a more physiologically relevant model for improved drug safety and efficacy screening

Find out how a pioneering precision medicine company is using cell counting technology to improve patient outcomes

Innovation and growth remain a priority to support customers and COVID-19 initiatives

Highly complementary cell counting and analysis capabilities bolster preclinical portfolio and enhance QA/QC capabilities in cell and gene therapy and biologics manufacturing

Simplified design reduces manufacturing time and offers improved functionality to help streamline antibody discovery, cell line development, cell therapy, and synthetic biology workflows

Explore topics from live-cell analysis, in situ hybridization, cancer therapeutics, cell imaging, and much more